Font Size:
a
A
A
Keyword [Structure-activity Relationships]
Result: 101 - 120 | Page: 6 of 7
101.
Design And Structure-activity Relationships Of Compounds For Adult Hippocampal Neurogenesis
102.
Design,Synthesis And Biological Evaluation Neuroprotection Activtity Of Celastrol Derivatives
103.
Design,synthesis And Biological Evaluation Of Novel 4-phenoxyquinoline Derivatives As C-Met Kinase Inhibitors
104.
Study On The Structure-Activity Relationship Of ?-Helix Peptide
105.
Design,Synthesis And Anti-melanoma Activity Of Derivatives Based On Compound THPN
106.
In Vitro Antioxidant Activity Of Natural Products From Microorganism In Special Eco-environment And Their Structure-Activity Relationships
107.
Nuclear receptor engineering based on novel structure activity relationships revealed by farnesyl pyrophosphate
108.
Molecular mechanisms of touch sensory transduction in Caenorhabditis elegans: Structure/activity relationships of degeneration channels in touch perception in Caenorhabditis elegans
109.
Peptoid mimics of helical, cationic antimicrobial peptides: Studies of structure-activity relationships, synergy, and mechanism
110.
Structure-activity relationships and thermodynamics of combretastatin A-4 and A-1 derivatives as potential inhibitors of tubulin polymerization
111.
Anticancer structure-activity relationships of semi-synthetic analogs of nordihydroguaiaretic acid
112.
In silico approaches for studying transporter and receptor structure-activity relationships
113.
I. The structure activity relationships and cytotoxic activity of analogs of tryprostatin A and B. Preparation of irreversible inhibitors for studies of mechanism of action. II. Pharmacophore/receptor models for the GABA(A)/Bz receptor subtypes
114.
A structure-activity approach to drug action in pharmacology: (A) Structure-activity relationships involved in DT-diaphorase (NQO1) mediated reduction kinetics and mode of action of anticancer bioreductive benzoquinone alkylating agents. (B) Structural c
115.
Novel computational chemistry models for exploring the structure-activity relationships of HIV-1 protease substrates and inhibitors (Immune deficiency)
116.
Isolation, synthesis, and biological properties of cyclic defensins: Structure-activity relationships and comparison with protegrin PG-1
117.
Synthesis of new glutamate receptor probes: I. Total synthesis of dysiherbaine, a potent glutamate receptor excitotoxin; II. Design and synthesis of dysiherbaine analogues; III. Synthesis and structure-activity relationships of substituted benzothiadiazi
118.
Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance (MDR) efflux pump: Synthesis and structure activity relationships
119.
Computer-aided development of quantitative structure-activity relationships and analysis of data from an artificial nose
120.
Structure activity relationships of topoisomerase inhibitors
<<First
<Prev
Next>
Last>>
Jump to